Sachin Jagdale – Mumbai
7th in-Pharma Japan, the international pharmaceutical ingredients expo and conference, will be held in Tokyo Big Sight, Japan from July 10-12, 2013. Reed Exhibitions Japan, the organiser of the conference, along with Indian Drug Manufacturers Association (IDMA) briefed senior Indian pharmaceutical professionals about the key highlights of the conference.
7th in-Pharma Japan is expected to attract more visitors than the previous year. During the event, exhibitors can make their products more visible through presentation sessions. An exclusive venue for exhibitors to hold a private presentation is available inside the exhibition hall. It is a cost effective way to publicise product to target buyers.
Chief executive officers, chief technical officers, presidents, vice presidents, and directors from major pharma companies across the globe will take part in the conference. Over 810,000 invitation tickets will be sent out to industry executives and professional in Japan and all over the world. Special support services for exhibitors also includes exclusive VIP customer registration system, VIP networking reception party, e-guidebook and web link service, press release services etc. Indian pharma manufactures could expect special benefits out of this conference as organisers have arranged for special counters for Indian delegates.
On the sidelines of briefing in Mumbai, Daara Patel, Secretary General, IDMA, presented the analysis of Indian and Japanese pharma market. “As India has an advantage of great breed of pharma talent, Indian pharma manufacturers need to capitalise on opportunities that Japanese pharma market offers,” he said.
Japan is the second largest pharma market in the world. About 70 per cent pharma ingredients for generic market in Japan are imported. This huge requirement also opens a gate of opportunity for Indian pharma manufacturers. Japan already has a few Indian pharma players operating on their soil.
- Advertisement -
